Trial Profile
Efficacy and Safety of Ziprasidone in the Treatment of Depressive Symptoms in Patients With Schizophrenia: an 8-week Open-label Study
Status:
Not yet recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 20 Dec 2010
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 20 Dec 2010 New trial record